Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea

Overview of attention for article published in Frontiers in endocrinology, June 2019

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 792 followers.

Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib ... https://t.co/wMRVApmWir

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.